Veeva Systems VEEV
Life sciences software. Veeva Systems Inc., listed on NYSE.
Based on the FY2026 annual report (Feb 2025 – Jan 2026)
Veeva Systems' market cap is
about $50.18 billion.
#215 by market cap among 289 companies, based on the Nov 5, 2026 close. FY2026 revenue was $3.195311B.
- Share price (close)
- $310.10
- P/E ratio
- 57.0x
- Market cap
- $50.18B
- Revenue
- $3.195311B
- Operating income
- $916.369M
- Net income
- $908.906M
- Free cash flow
- —
- Total assets
- $8.979343B
- Dividends paid
- —
- Dividend per share
- —
- Dividend yield
- —
- Shares outstanding
- 163,778,271 shares
Size, put in perspective
Calculated from the FY2026 annual report, spread evenly over 365 days.
Where the revenue went
Revenue is set at 100% and split into what went to costs, R&D, operating expenses and taxes, and what was left as profit.
- Cost of revenue24.5%
- R&D24.0%
- SG&A and other22.8%
- Taxes, interest & other0.2%
- Net income28.4%
Profitability and stability
Each figure comes with its rank among 300 companies. The further right the dot, the higher the rank.
- Revenue growthHow much revenue grew from the previous fiscal year
- +16.3%
- #68 of 299
- Revenue is growing steadily. The median across 299 companies is +7.9%.
- Operating marginShare of revenue kept as profit from the core business
- 28.7%
- #55 of 231
- 28.7% of revenue was kept as operating profit. The median across 231 companies is 19.2%.
- Net marginShare of revenue left as profit after interest and taxes
- 28.4%
- #45 of 298
- After taxes, 28.4% of revenue was left as net income. The median across 298 companies is 14.0%.
- FCF marginShare of revenue left as cash after capital spending
- —
- Not ranked
- Free cash flow based on capital spending isn't calculated for financial companies.
- ROEHow much profit the company earned on shareholders' equity in a year
- 13.9%
- #160 of 276
- Earnings relative to equity are about average. The median across 276 companies is 16.8%.
- Debt-to-equityLiabilities relative to equity. Lower means less debt
- 24.5%
- #7 of 244
- Liabilities are smaller than equity. The median across 244 companies is 159.6%.
Revenue and profit over time
Gray bars show revenue and the green part inside shows net income. The number above each bar is revenue (abbreviated) and the number below is net margin. Hover over a bar to see the exact amounts.
Where the cash went
Unlike profit, cash flow is money that actually came in and went out.
- Cash from operations$1.415225B
For financial companies, loans and investments drive cash flow rather than capital spending, so FCF isn’t calculated.
Whose money funds the assets
The company's assets, split into borrowed money (liabilities) and shareholders' money (equity).
- Total assets$8.979343B
- Total liabilities$1.764591B
- Total equity$7.214752B
- Cash and equivalents$1.421233B
Compared with similar companies
Based on each company's latest annual report, so fiscal year ends may differ.
Compare in detail| Company | Annual revenue | Net income | Revenue growth | Operating margin | Net margin |
|---|---|---|---|---|---|
| Veeva SystemsVEEV | $3.195311B | $908.906M | +16.3% | 28.7% | 28.4% |
| HumanaHUM | $129.664B | $1.188B | +10.1% | 2.1% | 0.9% |
| Agilent TechnologiesA | $6.948B | $1.303B | +6.7% | 21.3% | 18.8% |
| MedlineMDLN | $28.432B | $1.159B | +11.5% | 7.8% | 4.1% |
| NateraNTRA | $2.306113B | −$208.16M | +35.9% | −13.4% | −9.0% |
What the company does
Veeva sells cloud software for sales management, clinical trials and quality control at pharmaceutical and biotech companies.
The fiscal year ends around January each year.
Related companies: Humana, Agilent Technologies, Medline, Natera
Financial statements
Last 5 fiscal years. Currency: US dollars.
Show the table
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | 1.850777B | 2.15506B | 2.363673B | 2.746619B | 3.195311B |
| Cost of revenue | 503.678M | 609.405M | 677.291M | 699.636M | 782.019M |
| Gross profit | 1.347099B | 1.545655B | 1.686382B | 2.046983B | 2.413292B |
| R&D expense | 382.035M | 520.278M | 629.031M | 693.078M | 767.386M |
| Operating income | 505.496M | 459.091M | 429.334M | 691.435M | 916.369M |
| Pretax income | 512.311M | 509.096M | 588.023M | 919.381M | 1.194508B |
| Net income | 427.39M | 487.706M | 525.705M | 714.138M | 908.906M |
| EPS (diluted) | $2.63 | $3.00 | $3.22 | $4.32 | $5.44 |
| Operating cash flow | 764.463M | 780.47M | 911.339M | 1.090051B | 1.415225B |
| Total assets | 3.816465B | 4.804296B | 5.91092B | 7.339756B | 8.979343B |
| Total liabilities | 904.828M | 1.088044B | 1.266096B | 1.507383B | 1.764591B |
| Total equity | 2.911637B | 3.716252B | 4.644824B | 5.832373B | 7.214752B |
| Cash and equivalents | 1.13804B | 886.465M | 703.487M | 1.118785B | 1.421233B |
| Original filing | 10-K | 10-K | 10-K | 10-K | 10-K |
Source: SEC EDGAR filings for Veeva Systems Inc. · CIK 0001393052 · US-GAAP